Chronic Obstructive Pulmonary Disease and Health Coaching

Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:

The Effect of Health Coaching on Perceived Social Support in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05711654
• Other study ID #: Osmaniye Korkut Ata University
• Status: Recruiting
• Phase: N/A
• Start date: December 1, 2022
• Est. completion date: September 30, 2023

Study information

• Verified date: January 2023
• Source: Harran University
• Contact: Derya Tülüce, PhD
• Phone: +905052933587
• Email: drytlc87[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to determine the effect of the health coaching approach applied to patients with Chronic Obstructive Pulmonary Disease on the perceived social support of the patients.

Research Hypotheses:

H0: Health coaching approach has no effect on perceived social support in patients with COPD.

H1: Health coaching approach has an effect on perceived social support in patients with COPD.

Description:

The current study is in the design of a single-blind randomized controlled trial. Patients were randomized into intervention group (n:34) and control group (n=34). Coaching interview will be held once a week for 6-8 weeks with the patients in the coaching group. Coaching sessions will be based on the social support the patient receives from family and friends.

Both the coaching group and the control group will be given information about COPD. This information will be given face to face first. Later, the booklet of the training given will be delivered to the patients via message.

The data was collected using the socio-demographic information form,COPD Assessment Test (CAT), and Multidimensional Scale of Perceived Social Support (MSPSS).

Data Analysis will be done with SPSS package program

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 68
• Est. completion date: September 30, 2023
• Est. primary completion date: May 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• over 40 years old,

• diagnosed with COPD for at least 6 months,

• without stage III and IV heart failure,

• without any cancer diagnosis,

• no communication problems (such as those who do not have problems in expressing - themselves, no hearing problems),

• not diagnosed with cognitive and mental dysfunction (such as Alzheimer's, dementia, bipolar disorder, major depression)

• Patients who agree to participate in the study will be formed.

Exclusion Criteria:

• with any cancer

• with stage IV heart failure

• patients requiring clinical follow-up due to acute COPD exacerbation

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Behavioral:
• Health coaching
Coaching interview will be held with patients at regular intervals.

Locations

Country	Name	City	State
Turkey	Osmaniye Korkut Ata University	Osmaniye	Center

Sponsors (2)

Lead Sponsor	Collaborator
Harran University	Osmaniye Korkut Ata University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Social support	The social support levels perceived by the patients will be measured.The scale developed by Zimmet, Dahlem, Zimet, and Farley (1988) was adapted to Turkish by Eker et al. (2001) via its application to 50 psychiatry patients, 50 surgery patients and 50 normal individuals. The average participant age was 36. Multidimensional Scale of Perceived Social Support (MSPSS) is a 12-item scale with three sub-factors such as family, friends and significant other. Each sub-factor consists of four items. The scale is a 7-point Likert type including choices ranging from very strongly disagree (1) to very strongly agree (7). Higher scores obtained from the scale point to high levels of perceived social support.	A 6-8 week coaching interview will be held with each patient participating in the study. Each patient will be followed for a total of 20 weeks.
Secondary	symptom managament	Symptoms of Patients with COPD will be measured. The CAT was used to assess symptom burden in this study. The CAT, a patient-reported scale, evaluates the effect of COPD symptoms on an individual's health. The scale consists of eight items including cough, phlegm, chest tightness, breathlessness, activities, confidence, sleep and energy. Each item is rated on a six-point Likert scale ranging from 0 (no symptom) to 5 (very serious). The total score ranges from 0 to 40 points, with lower scores indicating better health status.	A 6-8 week coaching interview will be held with each patient participating in the study. Each patient will be followed for a total of 20 weeks.